Pricing Log in Create free account

Odyssey Therapeutics, Inc. (ODTX) vs Savara Inc. (SVRA)

Odyssey Therapeutics, Inc. and Savara Inc. are both Biotechnology companies. Odyssey Therapeutics, Inc. and Savara Inc. are of similar size ($907.3M and $899.9M). Across the 8 metrics below, Odyssey Therapeutics, Inc. leads on 6 and Savara Inc. on 2.

Valuation

Metric ODTX SVRA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.44 8.53 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (90.93%) (12.01%) (32.88%)
Free cash flow yield (16.19%) (9.04%) (23.13%)

Profitability

Metric ODTX SVRA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (105.48%) (51.96%)
Return on assets 0.00% (78.28%) (46.06%)
Return on invested capital (238.81%) (12,213.18%) 0.00%

Growth

Metric ODTX SVRA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) — (10.42%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ODTX SVRA Biotechnology median
Debt to equity 0.00 0.21 0.00
Current ratio 12.94 10.13 4.97
Net debt to EBITDA — 1.64 1.01

Dividend

Metric ODTX SVRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ODTX SVRA Biotechnology median
Market cap 907.34m 899.91m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack